Hong Kong-based biotech Insilico Medicine shifts IPO plan to city from New York South China Morning Post Nawigacja wpisu Algorithmic fairness in artificial intelligence for medicine and healthcare – Nature.com Qiming-Backed AI Drug Discovery Startup Insilico Medicine Files For Hong Kong IPO – Forbes
